Concepedia

Caroline Jochéms

CJ

Statistics

Publications

59

Citations

3.6K

H-Index

31

Active since

2004

Affiliations

National Cancer Institute(Current)

Center for Cancer Research

National Institutes of Health

University of Gothenburg

Karolinska Institutet

Caroline Jochéms is an author at National Cancer Institute specializing in cancer immunotherapy, oncology, and cancer immunology.

ORCID

Publications per year

2004–2025

59

Publications

59

Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti–PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells

Benjamin Boyerinas, Caroline Jochéms, Massimo Fantini et al. · Cancer Immunology Research · 2015 · 456 citations · Full text

, , +17

Effects of conventional therapeutic interventions on the number and function of regulatory T cells

Mario Roselli, Vittore Cereda, Maria Giovanna di Bari et al. · OncoImmunology · 2013 · 186 citations · Full text

, , +17

An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele

Caroline Jochéms, James W. Hodge, Massimo Fantini et al. · Oncotarget · 2016 · 182 citations · Full text

, , +16

First-in-Human Phase I Trial of a Tumor-Targeted Cytokine (NHS-IL12) in Subjects with Metastatic Solid Tumors

Julius Strauss, Christopher R. Heery, Joseph W. Kim et al. · Clinical Cancer Research · 2018 · 171 citations · Full text

, , +17

Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies

Julius Strauss, Margaret E. Gatti‐Mays, Byoung Chul Cho et al. · Journal for ImmunoTherapy of Cancer · 2020 · 159 citations · Full text

, , +17

1–5 of 59